Smartphones are widely owned by children in America, with a Pew Research Center survey finding that 95% of teens ages 13-17 ...
The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of ...
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Children who own smartphones by age 12 are at higher risk of lack of sleep, obesity and depression, a new study published ...
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...
There are few diagnostic terms in medicine more stigmatized than “obesity,” which affects 41.9% of U.S. adults over 20, according to the Centers for Disease Control and Prevention. But many doctors ...
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...
Ghrelin is a hormone your stomach makes that signals your body when you're hungry. You might think of it as an "on switch" for appetite. Your small intestine, pancreas, and brain also release small ...
A new wave of weight-loss pills, dubbed Ozempic 2.0, promises easier daily dosing, strong results and wider access, with FDA approval expected as early as 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback